These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 15866438)

  • 1. Pediatric meningosarcoma: clinical evolution and genetic instability.
    de Mesa RL; Sierrasesúmaga L; de Cerain AL; Calasanz MJ; Patiño-García A
    Pediatr Neurol; 2005 May; 32(5):352-4. PubMed ID: 15866438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of NF2 gene deletion in pediatric meningiomas using chromogenic in situ hybridization.
    Begnami MD; Rushing EJ; Santi M; Quezado M
    Int J Surg Pathol; 2007 Apr; 15(2):110-5. PubMed ID: 17478763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
    Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A
    Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correspondence of tumor localization with tumor recurrence and cytogenetic progression in meningiomas.
    Ketter R; Rahnenführer J; Henn W; Kim YJ; Feiden W; Steudel WI; Zang KD; Urbschat S
    Neurosurgery; 2008 Jan; 62(1):61-9; discussion 69-70. PubMed ID: 18300892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of meningioma with frequent relapses and a hyperhaploid stemline.
    Rønne M; Poulsgård L; Elberg JJ
    Anticancer Res; 1988; 8(4):545-7. PubMed ID: 3178146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution to malignancy in a recurrent meningioma: morphological and cytogenetic findings.
    Cerdá-Nicolás M; López-Ginés C; Barcia-Salorio J; Llombart-Bosch A
    Clin Neuropathol; 1998; 17(4):210-5. PubMed ID: 9707336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correspondence of tumor localization with tumor recurrence and cytogenetic progression in meningiomas.
    Palma L
    Neurosurgery; 2009 Jun; 64(6):E1206; author reply E1206. PubMed ID: 19487876
    [No Abstract]   [Full Text] [Related]  

  • 8. Evolution to malignancy: A genetic stepwise study of tumor suppressor genes loss in a recurrent meningioma.
    San-Miguel T; Cerdá-Nicolás M; Gil-Benso R; Callaghan RC; Muñoz-Hidalgo L; López-Ginés C
    Clin Neuropathol; 2015; 34(4):237-9. PubMed ID: 25817074
    [No Abstract]   [Full Text] [Related]  

  • 9. New recurrent deletions in the PPARgamma and TP53 genes are associated with childhood myelodysplastic syndrome.
    Silveira CG; Oliveira FM; Valera ET; Ikoma MR; Borgonovo T; Cavalli IJ; Tone LG; Rogatto SR
    Leuk Res; 2009 Jan; 33(1):19-27. PubMed ID: 18789822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of beta-catenin/E-cadherin in meningiomas.
    Brunner EC; Romeike BF; Jung M; Comtesse N; Meese E
    Histopathology; 2006 Aug; 49(2):178-87. PubMed ID: 16879395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the cell lines used in meningioma research.
    Ragel BT; Couldwell WT; Gillespie DL; Wendland MM; Whang K; Jensen RL
    Surg Neurol; 2008 Sep; 70(3):295-307; discussion 307. PubMed ID: 18261772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Her-2/neu gene amplification in paraffin-embedded tissue sections of meningioma patients.
    Ozer O; Sahin FI; Aydemir F; Ozen O; Yilmaz Z; Altinörs N
    Turk Neurosurg; 2009 Apr; 19(2):135-8. PubMed ID: 19431122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic findings in typical and atypical meningioma.
    Meloni A; Morgan R; Bridge J; Erling MA; Lewin RJ; Sandberg AA
    Cancer Genet Cytogenet; 1991 Jan; 51(1):35-9. PubMed ID: 1984845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-induced meningiomas: clinical, cytogenetic, and microarray features.
    Lillehei KO; Donson AM; Kleinschmidt-DeMasters BK
    Acta Neuropathol; 2008 Sep; 116(3):289-301. PubMed ID: 18604545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary leptomeningeal oligodendroglioma with documented progression to anaplasia and t(1;19)(q10;p10) in a child.
    Rossi S; Rodriguez FJ; Mota RA; Dei Tos AP; Di Paola F; Bendini M; Agostini S; Longatti P; Jenkins RB; Giannini C
    Acta Neuropathol; 2009 Oct; 118(4):575-7. PubMed ID: 19562354
    [No Abstract]   [Full Text] [Related]  

  • 16. Chromosomal instability mapping in meningioma.
    K Roukas D; Ragos V; S Mastronikolis N; Tsiambas E
    J BUON; 2018; 23(6):1931. PubMed ID: 30610828
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
    Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
    Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of metaplastic meningioma with extensive xanthomatous change.
    Ikota H; Nakazato Y
    Neuropathology; 2008 Aug; 28(4):422-6. PubMed ID: 18410275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytogenetic studies in meningioma].
    Kameyama J; Nakao H
    Rinsho Byori; 1989 Feb; Spec No 80():218-29. PubMed ID: 2630671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.